US Stock MarketDetailed Quotes

ADCT ADC Therapeutics

Watchlist

3.630
-0.190-4.97%

Close Jul 26 16:00 ET

3.520
-0.110-3.03%

Post 20:01 ET

349.30MMarket Cap-1310P/E (TTM)

ADC Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-186.48%-44.1M

14.19%-118.69M

38.31%-33.07M

-1,649.75%-34.02M

31.70%-36.2M

54.57%-15.39M

40.74%-138.31M

13.01%-53.61M

103.75%2.2M

8.62%-53.01M

Net income from continuing operations

21.50%-46.61M

-52.78%-240.05M

-236.29%-85.7M

5.53%-47.81M

26.73%-47.17M

-256.37%-59.37M

31.69%-157.13M

25.87%-25.49M

29.27%-50.61M

11.29%-64.37M

Operating gains losses

402.68%3.76M

-89.39%4.32M

-37.92%2.6M

-97.65%756K

-87.56%220K

-70.25%747K

564.72%40.69M

82.46%4.18M

1,351.94%32.23M

28.58%1.77M

Depreciation and amortization

16.60%843K

36.81%3.27M

58.96%1.01M

38.64%793K

26.28%740K

21.72%723K

-9.20%2.39M

-16.21%636K

-13.07%572K

-7.72%586K

Deferred tax

--0

2,388.96%37.1M

671.58%45.75M

-231.07%-578K

-93.37%-8M

98.21%-69K

93.78%-1.62M

122.76%5.93M

--441K

---4.14M

Other non cash items

349.13%6.93M

168.11%17.3M

-28.95%-6.1M

-42.75%8.3M

251.18%13.57M

105.89%1.54M

-48.97%-25.41M

49.54%-4.73M

30.12%14.49M

-2,395.40%-8.98M

Change In working capital

-130.15%-9.92M

190.86%44.27M

117.26%10.18M

104.82%224K

-94.20%955K

2,221.92%32.91M

-210.15%-48.73M

-972.28%-59M

66.05%-4.65M

853.36%16.47M

-Change in receivables

-95.92%2M

211.78%47.79M

91.95%-4M

211.53%2.7M

-96.81%188K

1,310.88%48.9M

-41.48%-42.75M

-246.94%-49.69M

82.49%-2.42M

383.26%5.89M

-Change in inventory

-63.22%-568K

40.81%-5.71M

90.53%-332K

-77.19%-3.3M

55.92%-1.73M

1.97%-348K

-219.36%-9.65M

-69.95%-3.51M

-26,714.29%-1.86M

-306.52%-3.93M

-Change in payables and accrued expense

69.99%-4.79M

-166.26%-10.97M

-175.60%-9.26M

-74.59%849K

492.65%13.4M

-464.20%-15.96M

-14.29%16.56M

25.38%12.25M

93.79%3.34M

-278.50%-3.41M

-Change in other current assets

-209.02%-701K

164.15%7.49M

166.41%8.08M

61.55%-1.27M

-99.16%41K

160.38%643K

-83.67%-11.67M

-310.77%-12.16M

-88.06%-3.31M

279.34%4.86M

-Change in other current liabilities

-1,719.57%-5.86M

571.74%5.68M

366.67%15.69M

-55.37%2.44M

-222.90%-12.14M

96.98%-322K

---1.2M

---5.88M

--5.47M

--9.88M

-Change in other working capital

----

1,228.33%3.19M

Cash from discontinued investing activities

Operating cash flow

-186.48%-44.1M

14.19%-118.69M

38.31%-33.07M

-1,649.75%-34.02M

31.70%-36.2M

54.57%-15.39M

40.74%-138.31M

13.01%-53.61M

103.75%2.2M

8.62%-53.01M

Investing cash flow

Cash flow from continuing investing activities

47.74%-531K

-368.12%-3.22M

-130.93%-527K

-160.24%-661K

-46.88%-1.01M

29.83%-1.02M

89.70%-687K

305.30%1.7M

89.14%-254K

75.81%-689K

Net PPE purchase and sale

47.74%-531K

-368.12%-3.22M

-61.68%-346K

-241.24%-662K

-2,284.00%-1.19M

-343.67%-1.02M

79.97%-687K

49.05%-214K

86.19%-194K

94.73%-50K

Net intangibles purchase and sale

----

101.67%1K

----

93.57%-60K

60.05%-759K

Net other investing changes

----

--0

----

--0

--120K

Cash from discontinued investing activities

Investing cash flow

47.74%-531K

-368.12%-3.22M

-130.93%-527K

-160.24%-661K

-46.88%-1.01M

29.83%-1.02M

89.70%-687K

305.30%1.7M

89.14%-254K

75.81%-689K

Financing cash flow

Cash flow from continuing financing activities

-16.24%356K

8,335.79%73.88M

159.56%1.64M

-197.55%-2.31M

29,511.90%74.12M

264.73%425K

-100.34%-897K

-125.94%-2.75M

-98.92%2.37M

-100.51%-252K

Net issuance payments of debt

----

--0

-53.54%866K

-100.36%-409K

----

137.79%115.6M

906.93%1.86M

49,987.77%114.24M

-100.51%-252K

Net common stock issuance

----

--0

----

--6.13M

---62K

----

Proceeds from stock option exercised by employees

-16.24%356K

--773K

----

--425K

--0

----

Net other financing activities

----

159.61%73.1M

--0

---1.9M

----

-156.25%-122.62M

-264.61%-4.55M

----

Cash from discontinued financing activities

Financing cash flow

-16.24%356K

8,335.79%73.88M

159.56%1.64M

-197.55%-2.31M

29,511.90%74.12M

264.73%425K

-100.34%-897K

-125.94%-2.75M

-98.92%2.37M

-100.51%-252K

Net cash flow

Beginning cash position

-14.66%278.6M

-30.03%326.44M

-18.50%310.41M

-7.77%347.51M

-27.93%310.55M

-30.03%326.44M

6.23%466.54M

-28.17%380.86M

1.32%376.78M

12.46%430.87M

Current changes in cash

-176.98%-44.27M

65.67%-48.03M

41.53%-31.96M

-958.92%-36.99M

168.40%36.9M

55.09%-15.98M

-611.63%-139.9M

14.16%-54.66M

-97.28%4.31M

-379.44%-53.95M

Effect of exchange rate changes

-148.31%-43K

188.46%184K

-37.45%152K

47.32%-118K

142.07%61K

208.54%89K

-3,566.67%-208K

737.93%243K

-229.41%-224K

-1,066.67%-145K

End cash Position

-24.56%234.29M

-14.66%278.6M

-18.50%310.41M

-7.77%347.51M

-27.93%310.55M

-30.03%326.44M

-28.17%380.86M

1.32%376.78M

Free cash flow

-171.98%-44.63M

12.30%-121.9M

35.92%-33.4M

-1,886.60%-34.68M

30.48%-37.42M

53.12%-16.41M

42.02%-139M

16.16%-52.12M

103.19%1.94M

11.57%-53.82M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-186.48%-44.1M	14.19%-118.69M	38.31%-33.07M	-1,649.75%-34.02M	31.70%-36.2M	54.57%-15.39M	40.74%-138.31M	13.01%-53.61M	103.75%2.2M	8.62%-53.01M
Net income from continuing operations	21.50%-46.61M	-52.78%-240.05M	-236.29%-85.7M	5.53%-47.81M	26.73%-47.17M	-256.37%-59.37M	31.69%-157.13M	25.87%-25.49M	29.27%-50.61M	11.29%-64.37M
Operating gains losses	402.68%3.76M	-89.39%4.32M	-37.92%2.6M	-97.65%756K	-87.56%220K	-70.25%747K	564.72%40.69M	82.46%4.18M	1,351.94%32.23M	28.58%1.77M
Depreciation and amortization	16.60%843K	36.81%3.27M	58.96%1.01M	38.64%793K	26.28%740K	21.72%723K	-9.20%2.39M	-16.21%636K	-13.07%572K	-7.72%586K
Deferred tax	--0	2,388.96%37.1M	671.58%45.75M	-231.07%-578K	-93.37%-8M	98.21%-69K	93.78%-1.62M	122.76%5.93M	--441K	---4.14M
Other non cash items	349.13%6.93M	168.11%17.3M	-28.95%-6.1M	-42.75%8.3M	251.18%13.57M	105.89%1.54M	-48.97%-25.41M	49.54%-4.73M	30.12%14.49M	-2,395.40%-8.98M
Change In working capital	-130.15%-9.92M	190.86%44.27M	117.26%10.18M	104.82%224K	-94.20%955K	2,221.92%32.91M	-210.15%-48.73M	-972.28%-59M	66.05%-4.65M	853.36%16.47M
-Change in receivables	-95.92%2M	211.78%47.79M	91.95%-4M	211.53%2.7M	-96.81%188K	1,310.88%48.9M	-41.48%-42.75M	-246.94%-49.69M	82.49%-2.42M	383.26%5.89M
-Change in inventory	-63.22%-568K	40.81%-5.71M	90.53%-332K	-77.19%-3.3M	55.92%-1.73M	1.97%-348K	-219.36%-9.65M	-69.95%-3.51M	-26,714.29%-1.86M	-306.52%-3.93M
-Change in payables and accrued expense	69.99%-4.79M	-166.26%-10.97M	-175.60%-9.26M	-74.59%849K	492.65%13.4M	-464.20%-15.96M	-14.29%16.56M	25.38%12.25M	93.79%3.34M	-278.50%-3.41M
-Change in other current assets	-209.02%-701K	164.15%7.49M	166.41%8.08M	61.55%-1.27M	-99.16%41K	160.38%643K	-83.67%-11.67M	-310.77%-12.16M	-88.06%-3.31M	279.34%4.86M
-Change in other current liabilities	-1,719.57%-5.86M	571.74%5.68M	366.67%15.69M	-55.37%2.44M	-222.90%-12.14M	96.98%-322K	---1.2M	---5.88M	--5.47M	--9.88M
-Change in other working capital	----	----	----	----	----	----	----	----	----	1,228.33%3.19M
Cash from discontinued investing activities
Operating cash flow	-186.48%-44.1M	14.19%-118.69M	38.31%-33.07M	-1,649.75%-34.02M	31.70%-36.2M	54.57%-15.39M	40.74%-138.31M	13.01%-53.61M	103.75%2.2M	8.62%-53.01M
Investing cash flow
Cash flow from continuing investing activities	47.74%-531K	-368.12%-3.22M	-130.93%-527K	-160.24%-661K	-46.88%-1.01M	29.83%-1.02M	89.70%-687K	305.30%1.7M	89.14%-254K	75.81%-689K
Net PPE purchase and sale	47.74%-531K	-368.12%-3.22M	-61.68%-346K	-241.24%-662K	-2,284.00%-1.19M	-343.67%-1.02M	79.97%-687K	49.05%-214K	86.19%-194K	94.73%-50K
Net intangibles purchase and sale	----	----	----	101.67%1K	----	----	----	----	93.57%-60K	60.05%-759K
Net other investing changes	----	----	----	--0	----	----	----	----	--0	--120K
Cash from discontinued investing activities
Investing cash flow	47.74%-531K	-368.12%-3.22M	-130.93%-527K	-160.24%-661K	-46.88%-1.01M	29.83%-1.02M	89.70%-687K	305.30%1.7M	89.14%-254K	75.81%-689K
Financing cash flow
Cash flow from continuing financing activities	-16.24%356K	8,335.79%73.88M	159.56%1.64M	-197.55%-2.31M	29,511.90%74.12M	264.73%425K	-100.34%-897K	-125.94%-2.75M	-98.92%2.37M	-100.51%-252K
Net issuance payments of debt	----	--0	-53.54%866K	-100.36%-409K	----	----	137.79%115.6M	906.93%1.86M	49,987.77%114.24M	-100.51%-252K
Net common stock issuance	----	--0	--0	----	----	----	--6.13M	---62K	----	----
Proceeds from stock option exercised by employees	-16.24%356K	--773K	----	----	----	--425K	--0	----	----	----
Net other financing activities	----	159.61%73.1M	--0	---1.9M	----	----	-156.25%-122.62M	-264.61%-4.55M	----	----
Cash from discontinued financing activities
Financing cash flow	-16.24%356K	8,335.79%73.88M	159.56%1.64M	-197.55%-2.31M	29,511.90%74.12M	264.73%425K	-100.34%-897K	-125.94%-2.75M	-98.92%2.37M	-100.51%-252K
Net cash flow
Beginning cash position	-14.66%278.6M	-30.03%326.44M	-18.50%310.41M	-7.77%347.51M	-27.93%310.55M	-30.03%326.44M	6.23%466.54M	-28.17%380.86M	1.32%376.78M	12.46%430.87M
Current changes in cash	-176.98%-44.27M	65.67%-48.03M	41.53%-31.96M	-958.92%-36.99M	168.40%36.9M	55.09%-15.98M	-611.63%-139.9M	14.16%-54.66M	-97.28%4.31M	-379.44%-53.95M
Effect of exchange rate changes	-148.31%-43K	188.46%184K	-37.45%152K	47.32%-118K	142.07%61K	208.54%89K	-3,566.67%-208K	737.93%243K	-229.41%-224K	-1,066.67%-145K
End cash Position	-24.56%234.29M	-14.66%278.6M	-14.66%278.6M	-18.50%310.41M	-7.77%347.51M	-27.93%310.55M	-30.03%326.44M	-30.03%326.44M	-28.17%380.86M	1.32%376.78M
Free cash flow	-171.98%-44.63M	12.30%-121.9M	35.92%-33.4M	-1,886.60%-34.68M	30.48%-37.42M	53.12%-16.41M	42.02%-139M	16.16%-52.12M	103.19%1.94M	11.57%-53.82M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall